Integrating Cost into Treatment

Alexander Bastian

Video Categories: Value

According to Alexander Bastian, it’s very difficult to determine how to integrate cost into the equation of cancer care. He explains that cost should be considered early on and uses Dr. Zafar’s term of financial toxicity, meaning the burden of cost can be as bad or worse than a physical side effect.
October 1, 2014

The Changing Role of Pharmacists

Hear Atheer Kaddis describe how the role of the pharmacist is changing in hematology and oncology.Supported through funding from Incyte

September 2, 2015

Changing the Way Takeda Oncology Develops Cancer Medicines

Dixie-Lee Esseltine, MD and George Mulligan, PhD offer insight on the impact of ixazomib on Takeda Oncology’s approach to multiple myeloma care and its approach to other cancer types.